Cytoskeletal Dynamics And Axonal Transport Pathway is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The cytoskeletal dynamics and axonal transport pathway describes how neurons use the cytoskeleton for intracellular transport, and how defects in this system lead to neurodegeneration. This pathway is fundamental to neuronal survival, synaptic function, and is disrupted in Alzheimer's disease, Parkinson's disease, ALS, and Huntington's disease. [1]
Neurons are highly polarized cells with long axons and dendrites that require efficient intracellular transport systems. The neuronal cytoskeleton consists of microtubules, actin filaments, and intermediate filaments, which serve as tracks for motor protein-mediated transport. Disruption of axonal transport leads to accumulation of cargoes, synaptic dysfunction, and ultimately neuronal death. [2]
| Component | Type | Function | Disease Relevance |
|---|---|---|---|
| βIII-Tubulin | Protein | Neuronal tubulin isoform | ALS mutations |
| MAP2 | Protein | Dendritic microtubule stabilization | AD tau competition |
| Tau | Protein | Microtubule binding, regulation | Hyperphosphorylated in AD |
| KIF5 | Kinesin | Anterograde transport | ALS mutations |
| KIF1A | Kinesin | Synaptic vesicle transport | Hereditary spastic paraplegia |
| KIF17 | Kinesin | NMDA receptor transport | Cognitive decline |
| DYNC1H1 | Dynein | Retrograde transport | ALS/dystonia mutations |
| Lis1 | Adaptor | Dynein regulator | Lissencephaly |
| JIP3 | Adaptor | Kinesin/dynein regulation | Axon guidance |
| dynactin | Complex | Dynein activator | Perry syndrome |
| Myosin-V | Motor | Synaptic vesicle capture | AD synaptic loss |
| Neurofilament-L/M/H | Proteins | Axonal caliber | AD/ALS/PD biomarkers |
| SPTA4 | Spectrin | Membrane skeleton | ALS modifier |
Neuronal microtubules are polymers of α- and β-tubulin:
The kinesin superfamily (KIFs) transports cargo from cell body to synapse:
Cytoplasmic dynein transports cargo toward the cell body:
Myosin V and VI mediate actin-based transport:
Axonal transport defects occur early in AD:
Dopaminergic neurons are particularly vulnerable:
Transport defects are central to motor neuron degeneration:
Axonal transport is disrupted by mutant huntingtin:
| Strategy | Target | Approach | Development Stage |
|---|---|---|---|
| Microtubule stabilizers | Tau dissociation | Taxol analogs, epothilone D | Clinical trials |
| Motor protein modulators | Kinesin/dynein | Small molecule activators | Preclinical |
| Mitochondrial transport | Mitochondria | P110 (Drp1 inhibitor) | Preclinical |
| Neurofilament reduction | NF aggregation | Antisense oligonucleotides | Preclinical |
| Gene therapy | Transport proteins | AAV-KIF5 delivery | Preclinical |
| Cytoskeletal modulators | Actin dynamics | CK-666 (Arp2/3 inhibitor) | Preclinical |
Axonal transport dysfunction can be monitored through:
The study of Cytoskeletal Dynamics And Axonal Transport Pathway has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Mandelkow E. Tau physiology and pathology in Alzheimer's disease. J Cell Biol. 2024. ↩︎ ↩︎
Hirokawa N. Neuronal cytoskeleton and transport in health and disease. Nat Rev Neurosci. 2025. ↩︎ ↩︎
Wang L, Brown A. A history of axonal transport. Traffic. 2022. ↩︎
Chu Y. Cytoskeletal changes in Parkinson's disease models. Neurobiol Aging. 2024. ↩︎
Brundin P. Synaptic dysfunction in neurodegenerative disorders. Brain. 2025. ↩︎